Castleview Partners’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8
Closed -$37 548
2024
Q2
$37 Hold
8
﹤0.01% 911
2024
Q1
$35 Hold
8
﹤0.01% 890
2023
Q4
$40 Hold
8
﹤0.01% 856
2023
Q3
$49 Hold
8
﹤0.01% 666
2023
Q2
$44 Hold
8
﹤0.01% 683
2023
Q1
$58 Hold
8
﹤0.01% 666
2022
Q4
$76 Hold
8
﹤0.01% 624
2022
Q3
$0 Sell
8
-193
-96% -$2.84K ﹤0.01% 609
2022
Q2
$345K Buy
201
+193
+2,413% +$4.83K 0.27% 80
2022
Q1
$0 Sell
8
-41
-84% -$1.74K ﹤0.01% 701
2021
Q4
$91 Buy
+49
New +$3.29K ﹤0.01% 821
2021
Q2
$1K Buy
+8
New +$693 ﹤0.01% 877

Other funds holding ACB

Castleview Partners's ACB Position: Q3 2024 in Review

Castleview Partners sold out of Aurora Cannabis (ACB) in Q3 2024, closing a stake of 8 shares — an estimated $37 sold.

Castleview Partners first reported a position in ACB in Q2 2021 and held it in 12 quarters. The position peaked at $345K in Q2 2022. 145 funds tracked by Wall St. Rank hold ACB as of Q3 2024.

  • Castleview Partners reported no remaining Aurora Cannabis position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 8 Aurora Cannabis shares in Q3 2024, an estimated $37.
  • Castleview Partners first reported a position in Aurora Cannabis in Q2 2021 and held it in 12 quarters.
  • Castleview Partners's Aurora Cannabis position peaked at $345K in Q2 2022.
  • 145 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.